(1S,2R)-(+)-2-Amino-1-Cyclopentanecarboxylic Acid Hydrochloride: Precision in Chiral Chemistry

Raising the Bar in Chiral Building Blocks

Bringing value to the pharmaceutical and research sectors starts with clean, reliable chiral intermediates. Working for years in the heart of synthesis labs, we’ve seen firsthand what happens when the finer details of stereochemistry are ignored: reactions stall, yields fall, and regulatory headaches sink progress. (1S,2R)-(+)-2-Amino-1-Cyclopentanecarboxylic Acid Hydrochloride answers the daily call for reliable stereochemistry—offering a chiral cyclopentane backbone, locked in its (1S,2R) configuration.

We manufacture this compound in batches that emphasize not only meeting, but anticipating customer requirements for absolute configuration and purity. Every reactor, every purification line, and every staff hand touches the project knowing a single misstep in the isomer profile can carry forward into wasted time and compounded costs for users. Hard lessons shaped this: from early days of tracking minor peaks on chiral HPLC, to the tedious cleanups after a racemate crept into a late-stage scale-up. So, our processes start with well-chosen raw materials that limit racemate introduction, progress with closed control of synthetic conditions, and end with rigorous chemical and chiral analysis at every checkpoint.

Specifications and Material Consistency

Usually, it’s not the broad parameters that cause trouble, but the little details: moisture content, type of hydrochloride salt, trace chiral impurities, or minor optical rotation drift. Satisfying GC, NMR, and chiral HPLC means nothing if those numbers don’t align over the long haul. Everything produced leaves our plant after passing through hands that have seen too many inconsistencies from alternate sources. We keep impurities less than 1%, optical purity above 99%, and offer transparent batch records on demand.

Packing isn’t an afterthought, either. If left unchecked, transportation and poor sealing can allow the hydrochloride form to absorb atmospheric moisture or degrade. We use lined containers, silica pouches, and careful labeling, not because it’s trendy, but because we’ve been on the other end—once having to re-dry and re-weigh dozens of kilos due to one slip in the packaging room. Storage recommendations are provided, not as routine boilerplate, but carved out from a long string of customer feedback and real-world transport trials.

Applications That Demand Reliability

This chiral amino acid earns respect primarily in advanced pharmaceutical research, where the structure and conformation dictate biological activity. We stand by our product’s consistent quality since it has been directly integrated into peptide structure activity studies, CNS-active scaffold exploration, and specific enzyme inhibitor design. Peptide chemists look for this specific stereoisomer to mimic constrained proline analogues. In these peptide applications, a single incorrect configuration won’t only diminish potency, it can create biological liabilities or upend lengthy clinical trial investments. That responsibility hangs over every batch, pushing continuous refinement of crystallization, washing, and isolation steps.

Our history with researchers doesn’t just stop at the supply. Supporting large custom syntheses and scale-up needs stems from prior partnerships with institutes under pressure to move fast but needing firm quality control. The hydrochloride salt helps improve handling—reducing basic amine volatility and enhancing solubility—facilitating both manual and automated dosing at the bench and kilo scales. Early adopters on our supply chain provided crucial insight, sharing back analytics after formulation or solid-state storage trials. These real-world inputs eventually re-shaped things like drying parameters and container sealing—ground-up improvements that show up in fewer customer complaints and higher return order rates.

Distinctive Features Compared to Other Cyclopentane Amino Acids

One recurring question we field involves how this specific (1S,2R) compound deviates from other cyclopentane-based amino acids, or why a hydrochloride salt is favored over a free base. Our team directly compares analytical data and user feedback across similar products monthly. What stands out is the subtle impact the (1S,2R) configuration delivers on downstream peptide folding and receptor binding—this directly alters biological function versus the (1R,2S) or mixed isomers. We’ve observed this particular form enhances stability in certain cyclic peptide structures, where the opposite enantiomer or a racemic blend lead to aggregation or lability.

Hydrochloride as a salt form isn’t arbitrary either. Labs and process chemists often report that the hydrochloride dissolves predictably in aqueous and mixed solvents, reduces static during solid transfer, and simplifies charge calculations for salt metering. People who once elected to source the free amine often returned after experiencing hygroscopic uptake or difficulty achieving homogeneous dissolution. Our own QC staff saw reduced variability testing the hydrochloride relative to the base—a practical, day-to-day advantage cemented into our procedures.

Some suppliers do offer cheaper, racemic or non-salt forms of cyclopentanecarboxylic acids. From extensive side-by-side testing, we know the risk this brings—difficult separations, uncertain analytical peaks, troublesome documentation, and repeated regulatory questioning once projects progress to preclinical or clinical validation. Not a theory—years ago, supporting a client’s regulatory submission for a peptide API uncovered unexpected chiral contamination that originated from a competitor’s racemic batch. From then on, the lesson hit home: skimping on quality at this fundamental building block level nearly always comes at much higher cost downstream.

Meeting the Scale and Documentation Demands of Industry

Manufacturing at scale in pharma and advanced chemistry isn’t just chemistry—it’s logistics, paperwork, documentation, and problem-solving. Delivering 100-gram research packs to universities sounds straightforward, but translating the same process up to 10 kilograms for a pharma pilot facility surfaces every possible flaw or gap in traceability. Over the years, we developed packaging systems for both small bench users and large kilo requirements, precisely because local and international customers demanded it.

We provide a transparent chain of documentation, from certificate of analysis and batch records down to validated chiral purity certifications. Regulatory scrutiny has forced the industry to tighten up processes, so it’s not enough to simply say what’s in the bottle—the actual chain of data stretching from raw material receipt to final COA undergoes audit and investigation. Once, a partner ran an unexpected chiral mismatch in a late-stage peptide program, which traced back to a mix-up in lot documentation from a low-cost supplier. Since adopting digital trace tracking, we minimized the risk of such events and improved overall confidence for both our team and the end users.

Anyone ordering at scale appreciates a partner that handles documentation with more precision than just ‘copy-pasting’ generic forms. Our support team routinely adapts documentation for users involved in IND filings, GMP submissions, and custom synthesis projects with unique reporting needs. Support for these complex, customer-facing demands didn’t spring up overnight: it grew out of countless interactions, real regulatory inspections, and learning through feedback (sometimes harsh, always valuable).

Pushing Beyond Standard Commodity Supply

Treating amino acid production as a generic exercise results in mediocrity. We believe in—and invest in—downstream value through consistent feedback. Looking at complaints, compliments, and even one-off ‘special requests’ reveals constant improvements. Our R&D and production staff collaborate on alterations to how we dry, package, seal, and certify each lot. These aren’t theoretical changes; they are shaped directly from the pain points and wins experienced in the field.

Several years back, a client on an aggressive development timeline faced delays due to melting point drift caused by residual water in the product. To address this, we rebuilt our final drying protocols, reconfigured storage rooms for tighter humidity control, and installed in-line moisture sensors for real-time adjustment. The issue was resolved, and both sides captured new knowledge to carry forward in future projects. It’s these closed feedback loops between our shop floor and customer labs that drive improvements far more effective than external audits or ‘industry best practices’ alone.

There’s sometimes pressure to chase low-cost options, unfamiliar suppliers, or unregistered traders for compounds like (1S,2R)-(+)-2-Amino-1-Cyclopentanecarboxylic Acid Hydrochloride. No one denies that chasing a cheaper reagent can free up a few budget lines. But those who’ve been on the hook for lost time, production cost overruns, or failed regulatory filings trace root causes back to uneven or poorly-documented basic building blocks. Our team carries scars from learning these lessons the hard way—and we now offer detailed transparency to prevent these mishaps for our clients.

Looking Down the Road: Innovation and Partnership

Chiral chemistry continues to push boundaries, with researchers demanding new ring systems, alternative protection chemistries, and better analytical clarity. We don’t step back and watch these changes from the sidelines. Partnering closely with academic labs and pharma industry leaders, we integrate their evolving feedback into process changes: greener reagents, solvent recovery, custom salt forms, or real-time inventory tracking for just-in-time delivery.

Peptide synthesis, one of the key drivers behind this product, looks very different today compared to a decade ago. Demand for tight amino acid configuration, low-level impurity tracking, and secure documentation grows ever more intense. Recognizing this, a development chemist in our company—for example—once led a revalidation of every analytical method, switching over to higher resolution LCMS and triple authentication with external standards. This level of internal engagement makes our output more than just a bag of powder or bottle of white solid; it scores the highest marks in repeatable synthesis and traceable chiral verification, ready for the next wave of innovation.

Collaborating with End Users for Smarter Solutions

Direct communication with our customers shapes much of what we do. More than one research group has come to us with an ‘impossible’ solubility request or concerns about scaling beyond pilot batches. From the firsthand lessons of running a manufacturing line, we know there is no such thing as a minor chiral impurity or inattention to batch variation. We’ve organized plant visits, training sessions, and collaborative troubleshooting workshops with partners looking to solve exactly these problems.

It’s this shared knowledge—gained on both the lab bench and manufacturing floor—that informs smarter choices about packaging, solvent selection, and documentation. For example, adjusting the pH treatment during workup can minimize hydrolysis and support extended shelf-life, while tweaks in crystallization temperature have allowed us to reach tighter particle size distributions. Both arose because users challenged us—and we put those challenges directly into new production strategies.

Conclusion: A Trusted Partner in Chiral Amino Acid Supply

Chirality plays a defining role in modern pharmaceutical synthesis, and (1S,2R)-(+)-2-Amino-1-Cyclopentanecarboxylic Acid Hydrochloride sits at the intersection of scientific rigor and practical manufacturing. Each batch reflects decades of accumulated expertise, lessons learned from the field, and a commitment to secure, traceable, and effective products. Teams at our company value more than technical results—they aim for relationships that build confidence and drive both science and industry forward.

Supplying this compound is far more than moving bottles out the door. It comes from a place of pride: pride in the equipment, the people, and the improvements these products help achieve in labs across the globe. For every gram sent, we see another project move a bit closer to clinical impact, regulatory approval, or an innovative published result. The trust placed in us charges a real responsibility, and every process innovation—big or small—bears out our long-standing commitment to get it right for every customer, every order, every time.